產(chǎn)品詳情
簡單介紹：
Anti-phospho-alpha Adducin (Thr445)抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-phospho-alpha Adducin (Thr445)抗體用于**組化實驗,WB實驗,相應(yīng)的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-phospho-alpha Adducin (Thr445)
Cat. Number:
Anti-phospho-alpha Adducin (Thr445)抗體KL-12961R
Quantity size:
0.1ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Adducins are a family Anti-phospho-alpha Adducin (Thr445)抗體of cytoskeletal proteins encoded by three genes (alpha, beta, gamma). Adducin is a heterodimeric protein that consists of related subunits, which are produced from distinct genes but share a similar structure. Alpha and beta adducin include a protease-resistant N-terminal region and a protease-sensitive, hydrophilic C-terminal region. Alpha and gamma adducins are ubiquitously expressed. In contrast, beta adducin is expressed at high levels in brain and hematopoietic tissues. Adducin binds with high affinity to Ca2+/calmodulin and is a substrate for protein kinases A and C. Alternative splicing results in multiple variants encoding distinct isoforms; however, not all variants have been fully described.
Also known as:
Anti-phospho-alpha Adducin (Thr445)抗體Adducin (phospho T445); p-Adducin (phospho T445); ADD1; ADDA; Adducin 1 (alpha); Adducin 1; Alpha adducin; ADDA_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthesised phosphopeptide derived from human alpha Adducin around the phosphorylation site of Thr445.
●
Predicted Anti-phospho-alpha Adducin (Thr445)抗體Molecular Weight: 80kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Anti-phospho-alpha Adducin (Thr445)抗體Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Anti-phospho-alpha Adducin (Thr445)抗體Optimal working dilutions must be determined by the end user.
kl391Mu01 肌動蛋白γ1(ACTγ1)多克隆抗體 Polyclonal Antibody to Actin Gamma 1 (ACTg1)
kl972Mu02 色素上皮衍生因子(PEDF)多克隆抗體 Polyclonal Antibody to Pigment Epithelium Derived Factor (PEDF)
kl554Hu02 賴氨酰氧化酶樣蛋白4(LOXL4)多克隆抗體 Polyclonal Antibody to Lysyl Oxidase Like Protein 4 (LOXL4)
kl718Hu02 亮氨酸豐富重復FLII相互作用蛋白1(LRRFIP1)多克隆抗體 Polyclonal Antibody to Leucine Rich Repeat In FLII Interacting Protein 1 (LRRFIP1)
kl572Hu01 Ⅱ型膠原(COL2)多克隆抗體 Polyclonal Antibody to Collagen Type II (COL2)
kl711Mu02 肝素酶(HPA)多克隆抗體 Polyclonal Antibody to Heklanase (HPA)
kl134Ra02 黑色素瘤關(guān)聯(lián)硫酸軟骨素蛋白聚糖(MCSP)多克隆抗體 Polyclonal Antibody to Melanoma Associated Chondroitin Sulfate Proteoglycan (MCSP)
kl796Mu01 精氨酸酶Ⅱ(Arg2)多克隆抗體 Polyclonal Antibody to Arginase II (Arg2)
kl346Hu01 Reprimo蛋白(RPRM)多克隆抗體 Polyclonal Antibody to Reprimo (RPRM)
kl437Hu02 多溴蛋白1(PBRM1)多克隆抗體 Polyclonal Antibody to Polybromo 1 (PBRM1)
kl081Ra01 70kDa熱休克蛋白1A(HSPA1A)多克隆抗體 Polyclonal Antibody to Heat Shock 70kDa Protein 1A (HSPA1A)
kl418Mu02 過氧化氫酶(CAT)多克隆抗體 Polyclonal Antibody to Catalase (CAT)
kl363Mu02 血小板內(nèi)皮細胞粘附分子1(PECAM1)多克隆抗體 Polyclonal Antibody to Platelet/Endothelial Cell Adhesion Molecule (PECAM1)
kl561Hu01 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl561Mu03 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl692Ra03 神經(jīng)纖維網(wǎng)蛋白1(NRP1)多克隆抗體 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl775Ra01 己糖激酶1(HK1)多克隆抗體 Polyclonal Antibody to Hexokinase 1 (HK1)
kl032Mu02 磷脂酰肌醇蛋白聚糖1(GPC1)多克隆抗體 Polyclonal Antibody to Glypican 1 (GPC1)
kl258Ra02 谷氨酸脫羧酶2(GAD2)多克隆抗體 Polyclonal Antibody to Glutamate Decarboxylase 2, Acid (GAD2)
kl447Mu02 乙酰膽堿酯酶(AchE)多克隆抗體 Polyclonal Antibody to Acetylcholinesterase (AchE)
kl482Mu01 唾液淀粉酶α1(AMY1)多克隆抗體 Polyclonal Antibody to Amylase Alpha 1, Salivary (AMY1)
kl030Hu02 凋亡相關(guān)因子(FAS)多克隆抗體 Polyclonal Antibody to Factor Related Apoptosis (FAS)
